Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Active & Responsive
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Dallas TX, Oklahoma City OK, Austin TX, Edmond OK,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07484217
Phase 3, Recruiting
Active & Responsive
Healthy Living BEYOND Weight Study
for
Overweight or Obesity
Location: Dallas TX
Sponsor: American Heart Association
Sex: All
Age: 18+
Code: NCT07075341
Recruiting
Active & Responsive
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: Dallas TX, Fargo ND
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase 1, Recruiting
Active & Responsive
CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes
for
Otitis Media, Otitis Media Chronic, Otitis Media Effusion,
Location: Mesquite TX, Louisville KY
Sponsor: ClinQure, Inc.
Sex: All
Age: 0+
Code: NCT07625657
Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Dallas TX, Frisco TX, San Antonio TX, Nashville TN,
Sponsor: Apogee Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07003425
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Location: Dallas TX, St Louis MO, Birmingham AL, Atlanta GA,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT05552157
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Dallas TX, Houston TX, San Antonio TX, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase 3, Recruiting
Active & Responsive
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Location: Dallas TX, Houston TX, Little Rock AR, Atlanta GA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4+
Code: NCT05589714
Recruiting
Active & Responsive
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
for
Age-Related Macular Degeneration
Location: Dallas TX, Southaven MS, Pensacola FL, Atlanta GA,
Sponsor: Astellas Institute for Regenerative Medicine